nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinical audit in a multidisciplinary care path for thoracic surgery: An instrument for continuous quality improvement
|
Numan, Rachel C. |
|
2012 |
78 |
3 |
p. 270-275 6 p. |
artikel |
2 |
A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan
|
Nawa, Takeshi |
|
2012 |
78 |
3 |
p. 225-228 4 p. |
artikel |
3 |
Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: A case report
|
Falk, Alexander T. |
|
2012 |
78 |
3 |
p. 282-284 3 p. |
artikel |
4 |
An accurate and rapid detection of lymph node metastasis in non-small cell lung cancer patients based on one-step nucleic acid amplification assay
|
Inoue, Masayoshi |
|
2012 |
78 |
3 |
p. 212-218 7 p. |
artikel |
5 |
Analysis of “dry” mesothelioma with ultrasound guided biopsies
|
Stigt, Jos A. |
|
2012 |
78 |
3 |
p. 229-233 5 p. |
artikel |
6 |
Analysis of EGFR, KRAS and P53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy
|
Yamaguchi, Fumihiro |
|
2012 |
78 |
3 |
p. 201-206 6 p. |
artikel |
7 |
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin
|
Reck, Martin |
|
2012 |
78 |
3 |
p. 276-281 6 p. |
artikel |
8 |
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)
|
Zappa, Francesco |
|
2012 |
78 |
3 |
p. 239-244 6 p. |
artikel |
9 |
Contents
|
|
|
2012 |
78 |
3 |
p. vii-viii nvt p. |
artikel |
10 |
Editorial Board
|
|
|
2012 |
78 |
3 |
p. v- 1 p. |
artikel |
11 |
Impact of age on epidermal growth factor receptor mutation in lung cancer
|
Ueno, Tsuyoshi |
|
2012 |
78 |
3 |
p. 207-211 5 p. |
artikel |
12 |
Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer
|
Connolly, G.C. |
|
2012 |
78 |
3 |
p. 253-258 6 p. |
artikel |
13 |
Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)
|
Schnabel, Philipp A. |
|
2012 |
78 |
3 |
p. 263-269 7 p. |
artikel |
14 |
Lung cancer mortality in European women: Trends and predictions
|
Bosetti, Cristina |
|
2012 |
78 |
3 |
p. 171-178 8 p. |
artikel |
15 |
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy
|
Abelson, Jonathan A. |
|
2012 |
78 |
3 |
p. 219-224 6 p. |
artikel |
16 |
Neutral risk of lung cancer in adults with celiac disease – nationwide cohort study
|
Ludvigsson, Jonas F. |
|
2012 |
78 |
3 |
p. 179-184 6 p. |
artikel |
17 |
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network
|
Ritzwoller, Debra P. |
|
2012 |
78 |
3 |
p. 245-252 8 p. |
artikel |
18 |
Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells
|
Tezuka, Yasuhiro |
|
2012 |
78 |
3 |
p. 185-192 8 p. |
artikel |
19 |
Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set
|
Fibla, Juan J. |
|
2012 |
78 |
3 |
p. 259-262 4 p. |
artikel |
20 |
Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage
|
Collaud, Stéphane |
|
2012 |
78 |
3 |
p. 234-238 5 p. |
artikel |
21 |
The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines
|
Shen, Lan |
|
2012 |
78 |
3 |
p. 193-200 8 p. |
artikel |